What is the global market size of Anatomic Pathology Market?

Anatomic Pathology Market size was valued at USD 35.21 billion in 2021 and is poised to grow from USD 37.71 billion in 2022 to USD 65.54 billion by 2030, growing at a CAGR of 7.3% in the forecast period (2023-2030).

Who are the key vendors in the Global Anatomic Pathology Market?

Global anatomic pathology market is fairly consolidated with the presence of many well-known international and regional companies operating around the globe. Major players of the market are implementing on several business strategies including research & development, new product launches, collaborations, mergers, and partnerships to maintain their market share and expand their product portfolio to reach a wider consumer base. 'F. Hoffmann-La Roche AG', 'Danaher Corporation', 'Thermo Fisher Scientific Inc.', 'Becton, Dickinson and Company', 'Hologic, Inc.', 'Sakura Finetek Japan Co., Ltd.', 'Agilent Technologies, Inc.', 'Quest Diagnostics Incorporated', 'Laboratory Corporation of America Holdings', 'Bio-Rad Laboratories, Inc.', 'Merck KGaA', 'Siemens AG', 'Cell Signaling Technology, Inc.', 'PerkinElmer Inc.', 'Enzo Life Sciences, Inc.', 'Abcam plc', 'Epitomics, Inc.', 'Biocare Medical, LLC', 'Ventana Medical Systems, Inc.', 'Leica Biosystems Nussloch GmbH'

Anatomic Pathology Market Size

SkyQuest Technology's Anatomic pathology market size, share and forecast Report is based on the analysis of market data and Industry trends impacting the global Anatomic Pathology Market and the revenue of top companies operating in it. Market Size Data and Statistics are based on the comprehensive research by our Team of Analysts and Industry experts.

Anatomic Pathology Market Insights

Anatomic Pathology Market size was valued at USD 37.71 Billion in 2023 and is poised to grow from USD 40.46 Billion in 2024 to USD 70.32 Billion by 2032, growing at a CAGR of 7.3% during the forecast period (2025-2032).

An extensive rise in the use of clinical biomarkers to determine diseases pathogenesis at very molecular level enables the pathologists to enhance clinical decision making and improve patient outcomes are the factors anticipated to drive the growth of the global anatomic pathology market over the forecast period. Furthermore, the rising prevalence of biomarker-based pathology tests and further procedures for the exploration of malignancy and tumorigenesis is also driving the global demand and growth for anatomic pathology in the coming years.

Moreover, high usage of advanced technology in pathology equipment such as staining systems, digital microscopes, and gross imaging and adoption of these technologies in developing countries such as India and China are expected to foster market growth during the forecast period. Additionally, several major companies are focusing on development and improvement of pathology devices along with the design and ease of use. For instance, in May 2021, OptraSCAN, a leading pathology solutions provider introduced its new and advanced CytoSiA-an intelligent solution for fast scanning, analysis of pap smears, and at an affordable cost.

In addition, various business partnerships, collaborations, and agreement ventures among key market players for the introduction to new and innovative products and expanding their product portfolio are also projected to fuel the demand for global anatomic pathology market during the forecast period. For instance, in April 2021, Royal Philips announced its collaboration with Ibex Medical Analytics, an AI-based cancer diagnostics service provider. The main aim behind this collaboration is to boost the adoption and implement of AI-based pathology across the globe.

US Anatomic Pathology Market is poised to grow at a sustainable CAGR for the next forecast year.

Anatomic Pathology Market Report Snapshots

REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?

REQUEST FREE CUSTOMIZATION

FAQs

Global anatomic pathology market is fairly consolidated with the presence of many well-known international and regional companies operating around the globe. Major players of the market are implementing on several business strategies including research & development, new product launches, collaborations, mergers, and partnerships to maintain their market share and expand their product portfolio to reach a wider consumer base. 'F. Hoffman-LA Roche Ltd. ', 'Danaher Corporation ', 'PHC Holdings Corporation ', 'Abcam Plc. ', 'Hologic, Inc. ', 'Agilent Technologies ', 'Becton, Dickinson And Company ', 'Sakura Finetek USA Inc. ', 'Merck KGAA ', 'Bio SB ', 'Quest Diagnostics Incorporated ', 'Laboratory Corporation of America Holdings ', 'Cardinal Health ', 'NeoGenomics Laboratories, Inc. ', 'BioGenex ', 'Thermo Fisher Scientific Inc. ', 'Bio-Rad Laboratories, Inc. ', 'Siemens AG ', 'Cell Signaling Technology, Inc. ', 'PerkinElmer Inc.'

The increasing prevalence of various types of chronic diseases, as well as changes in consumer lifestyle and food habits, are the key major factors expected to drive the global anatomic pathology market during the forecast period. According to our findings, the global population of people over the age of 65 was around 727 million in 2020 and is expected to reach 1.5 billion by 2050. Since then, the tremendous growth in the global population of the elderly is expected to create significant growth opportunities for the anatomic pathology market in the coming years.

Increasing usage of advanced pathology equipment like digital microscopes, staining systems, and gross imaging is creating lucrative growth opportunities for the global market over the coming years. The features such as providing accuracy, specificity over the conventional techniques, and ease to use are enhancing the adoption of advanced anatomic pathology devices around the globe, thereby, the market is witnessing a strong growth in the coming years.

Globally, North America dominated the anatomic pathology market and accounted for the largest market share in 2021 and its set to continue this dominance throughout the forecast period. Increasing implementation of digital pathology, early adoption of advanced imaging tools, and rising consumer awareness regarding regular health screening are the few major factors likely to drive the growth of the market in the region over the coming years. In addition, presence of many well-known market players such as Pfizer Inc., Johnson & Johnson Pvt Ltd., and Abbott Laboratories in the region is also propelling the growth of the anatomic pathology market.

Anatomic Pathology Market Size

Anatomic Pathology Market Insights

Anatomic Pathology Market Report Snapshots

FAQs

What is the global market size of Anatomic Pathology Market?

Who are the key vendors in the Anatomic Pathology Market?

What is the key driver of Anatomic Pathology Market?

What is the key market trend for Anatomic Pathology Market?

Which region accounted for the largest share in Anatomic Pathology Market?

Request Free Customization